NIAGEN+
BRAND IDENTITY AND CREATIVE STRATEGY, WEBSITE CONTENT, LAUNCH CAMPAIGN, D2C AND HCP CONTENT, AND MORE
Part of my time at ChromaDex was spent gearing up for the company’s first foray into the pharmaceutical space—an intravenous version of the flagship NAD-booster Niagen, for consumer use (by prescription). While the product itself was in development and testing to clear FDA category 503b status over the course of a couple years, the creative, marketing, science, and legal teams worked together toward building marketing collateral for launch.
Once key study results were released, we were able to lean into intravenous Niagen’s superior efficacy, duration, and comfort compared to the NAD+ IVs dominating the current market. We focused on building awareness for new consumers as well as existing Tru Niagen supplement users, and connecting with HCPs, wellness clinics, and med spas on the B2C side.
Early splash page website and more evolved website:
Prelaunch and HCP/consumer data collection emails:
Pharmacy and clinician brochures:
